ESG Report

Overview

The report is Arcutis Biotherapeutics' first ESG report, covering 2021 progress while also presenting selected 2022 developments. It describes a cross-functional ESG team, an ESG leader, and full-board review of sustainability disclosures. Workforce disclosures include 52% women in the workforce, 32% women in leadership roles, and 40% female board representation as of October 1, 2022. The report also highlights employee development, community volunteering and charitable giving, recyclable packaging, and office-level environmental practices.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services